Protagonist Therapeutics Inc

NASDAQ:PTGX   12:38:46 PM EDT
9.92
-0.22 (-2.17%)
Earnings Announcements

Protagonist Therapeutics Inc - QTRLY Loss Per Share $0.84

Published: 08/04/2022 21:27 GMT
Protagonist Therapeutics Inc (PTGX) - Protagonist Reports Second Quarter 2022 Financial Results and Provides Corporate Update.
Strong Cash Position, With Cash Runway Through End of 2024.
Qtrly Loss per Share $0.84.
Q2 Earnings per Share View $-0.93 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$0.94

Next Quarter Revenue Guidance is expected to be $7.73 Million
Next Quarter EPS Guidance is expected to be -$0.80

More details on our Analysts Page.